Symbol:
Fanci
Name:
FA complementation group I
RGD ID:
2321863
Description:
Predicted to enable DNA polymerase binding activity. Predicted to be involved in DNA repair. Predicted to act upstream of or within positive regulation of protein ubiquitination. Predicted to be located in cytosol and nucleoplasm. Predicted to be part of DNA repair complex. Human ortholog(s) of this gene implicated in Fanconi anemia; Fanconi anemia complementation group I; and female breast cancer. Orthologous to human FANCI (FA complementation group I); INTERACTS WITH 1-naphthyl isothiocyanate; 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
Fanconi anemia, complementation group I; LOC100360594
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
FANCI (FA complementation group I) HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Fanci (Fanconi anemia, complementation group I) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Fanci (FA complementation group I) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
FANCI (FA complementation group I) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
FANCI (FA complementation group I) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Fanci (FA complementation group I) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
FANCI (FA complementation group I) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
FANCI (FA complementation group I) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Fanci (FA complementation group I) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
ATF7IP2 (activating transcription factor 7 interacting protein 2) HGNC
OMA
Alliance orthologs 3
Mus musculus (house mouse):
Fanci (Fanconi anemia, complementation group I)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
FANCI (FA complementation group I)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
fanci (FA complementation group I)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
FANCI
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB)
Xenopus tropicalis (tropical clawed frog):
fanci
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 142,736,636 - 142,792,999 (+) NCBI GRCr8 mRatBN7.2 1 133,327,264 - 133,383,661 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 133,327,297 - 133,383,640 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 1 141,116,565 - 141,172,997 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 141,120,166 - 141,172,483 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 142,078,658 - 142,134,772 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 135,144,029 - 135,196,828 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 1 125,390,494 - 125,446,830 (+) NCBI Celera Cytogenetic Map 1 q31 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Fanci Rat 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FANCI mRNA CTD PMID:30723492 Fanci Rat 17beta-estradiol increases expression ISO FANCI (Homo sapiens) 6480464 Estradiol results in increased expression of FANCI mRNA CTD PMID:16474171 and PMID:19167446 Fanci Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of FANCI mRNA CTD PMID:32145629 Fanci Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Fanci (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Fanci Rat 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Fanci (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Fanci Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO FANCI (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of FANCI mRNA CTD PMID:22574217 Fanci Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FANCI mRNA CTD PMID:32109520 and PMID:33387578 Fanci Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fanci (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FANCI mRNA CTD PMID:21570461 Fanci Rat 2-methylcholine affects expression ISO FANCI (Homo sapiens) 6480464 beta-methylcholine affects the expression of FANCI mRNA CTD PMID:21179406 Fanci Rat 2-palmitoylglycerol increases expression ISO FANCI (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of FANCI mRNA CTD PMID:37199045 Fanci Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO FANCI (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FANCI mRNA CTD PMID:28628672 Fanci Rat 4,4'-sulfonyldiphenol multiple interactions ISO FANCI (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FANCI mRNA CTD PMID:28628672 Fanci Rat 5-fluorouracil affects response to substance ISO FANCI (Homo sapiens) 6480464 FANCI protein affects the susceptibility to Fluorouracil CTD PMID:15548681 Fanci Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FANCI mRNA CTD PMID:30047161 Fanci Rat aflatoxin B1 affects expression ISO FANCI (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of FANCI protein CTD PMID:20106945 Fanci Rat Aflatoxin B2 alpha decreases methylation ISO FANCI (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of FANCI intron CTD PMID:30157460 Fanci Rat all-trans-retinoic acid decreases expression ISO FANCI (Homo sapiens) 6480464 Tretinoin results in decreased expression of FANCI mRNA CTD PMID:33167477 Fanci Rat amitrole increases expression EXP 6480464 Amitrole results in increased expression of FANCI mRNA CTD PMID:30047161 Fanci Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of FANCI mRNA CTD PMID:30779732 Fanci Rat arsane multiple interactions ISO FANCI (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FANCI mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FANCI mRNA CTD PMID:39836092 Fanci Rat arsenic atom multiple interactions ISO FANCI (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FANCI mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FANCI mRNA CTD PMID:39836092 Fanci Rat arsenite(3-) multiple interactions ISO FANCI (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to FANCI mRNA] CTD PMID:32406909 Fanci Rat asbestos affects response to substance ISO FANCI (Homo sapiens) 6480464 FANCI alternative form affects the susceptibility to Asbestos CTD PMID:28687356 Fanci Rat avobenzone increases expression ISO FANCI (Homo sapiens) 6480464 avobenzone results in increased expression of FANCI mRNA CTD PMID:31016361 Fanci Rat azathioprine decreases expression ISO FANCI (Homo sapiens) 6480464 Azathioprine results in decreased expression of FANCI mRNA CTD PMID:22623647 Fanci Rat benzo[a]pyrene decreases expression ISO FANCI (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of FANCI mRNA CTD PMID:20064835 Fanci Rat benzo[a]pyrene increases expression ISO FANCI (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of FANCI mRNA CTD PMID:32234424 Fanci Rat benzo[a]pyrene decreases methylation ISO FANCI (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of FANCI promoter CTD PMID:27901495 Fanci Rat benzo[a]pyrene decreases methylation ISO Fanci (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of FANCI intron CTD PMID:27901495 Fanci Rat benzo[a]pyrene increases expression ISO Fanci (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of FANCI mRNA CTD PMID:32417428 Fanci Rat benzo[a]pyrene diol epoxide I increases expression ISO FANCI (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 Fanci Rat bis(2-ethylhexyl) phthalate increases expression ISO Fanci (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of FANCI mRNA CTD PMID:34319233 Fanci Rat bisphenol A increases expression ISO FANCI (Homo sapiens) 6480464 bisphenol A results in increased expression of FANCI mRNA CTD PMID:16474171 Fanci Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FANCI mRNA CTD PMID:32145629 Fanci Rat bisphenol A decreases expression ISO FANCI (Homo sapiens) 6480464 bisphenol A results in decreased expression of FANCI mRNA CTD PMID:29275510 Fanci Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FANCI mRNA CTD PMID:25181051 Fanci Rat Bisphenol A diglycidyl ether affects splicing ISO Fanci (Mus musculus) 6480464 bisphenol A diglycidyl ether affects the splicing of FANCI mRNA CTD PMID:36464114 Fanci Rat bisphenol AF affects splicing ISO Fanci (Mus musculus) 6480464 bisphenol AF affects the splicing of FANCI mRNA CTD PMID:36464114 Fanci Rat bisphenol F decreases expression ISO Fanci (Mus musculus) 6480464 bisphenol F results in decreased expression of FANCI mRNA CTD PMID:38685157 Fanci Rat cadmium atom decreases expression ISO FANCI (Homo sapiens) 6480464 Cadmium results in decreased expression of FANCI mRNA CTD PMID:21120746 Fanci Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of FANCI mRNA CTD PMID:33453195 Fanci Rat cadmium dichloride decreases expression ISO FANCI (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of FANCI mRNA CTD PMID:38568856 Fanci Rat caffeine affects phosphorylation ISO FANCI (Homo sapiens) 6480464 Caffeine affects the phosphorylation of FANCI protein CTD PMID:35688186 Fanci Rat calcitriol decreases expression ISO FANCI (Homo sapiens) 6480464 Calcitriol results in decreased expression of FANCI mRNA CTD PMID:21592394 Fanci Rat calcitriol multiple interactions ISO FANCI (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of FANCI mRNA CTD PMID:21592394 Fanci Rat cannabidiol decreases expression ISO FANCI (Homo sapiens) 6480464 Cannabidiol results in decreased expression of FANCI mRNA CTD PMID:36519830 Fanci Rat cantharidin increases expression ISO Fanci (Mus musculus) 6480464 Cantharidin results in increased expression of FANCI mRNA CTD PMID:36907384 Fanci Rat carbamazepine affects expression ISO FANCI (Homo sapiens) 6480464 Carbamazepine affects the expression of FANCI mRNA CTD PMID:25979313 Fanci Rat carbon nanotube increases expression ISO Fanci (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Fanci Rat chlorpyrifos decreases expression ISO Fanci (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of FANCI mRNA CTD PMID:37019170 Fanci Rat cisplatin increases phosphorylation ISO Fanci (Mus musculus) 6480464 Cisplatin results in increased phosphorylation of FANCI protein CTD PMID:22006019 Fanci Rat cisplatin increases expression ISO FANCI (Homo sapiens) 6480464 Cisplatin results in increased expression of FANCI mRNA CTD PMID:27594783 Fanci Rat clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of FANCI mRNA CTD PMID:30047161 Fanci Rat cobalt dichloride decreases expression ISO FANCI (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of FANCI mRNA CTD PMID:19376846 Fanci Rat corosolic acid decreases expression ISO FANCI (Homo sapiens) 6480464 corosolic acid results in decreased expression of FANCI mRNA CTD PMID:37939859 Fanci Rat coumarin increases phosphorylation ISO FANCI (Homo sapiens) 6480464 coumarin results in increased phosphorylation of FANCI protein CTD PMID:35688186 Fanci Rat coumestrol multiple interactions ISO FANCI (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 Fanci Rat coumestrol increases expression ISO FANCI (Homo sapiens) 6480464 Coumestrol results in increased expression of FANCI mRNA CTD PMID:19167446 Fanci Rat Cuprizon affects expression EXP 6480464 Cuprizone affects the expression of FANCI mRNA CTD PMID:27523638 Fanci Rat curcumin multiple interactions ISO FANCI (Homo sapiens) 6480464 Curcumin inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCI protein] CTD PMID:24124520 Fanci Rat curcumin decreases expression ISO FANCI (Homo sapiens) 6480464 Curcumin results in decreased expression of FANCI mRNA CTD PMID:24124520 Fanci Rat cyclosporin A decreases expression ISO FANCI (Homo sapiens) 6480464 Cyclosporine results in decreased expression of FANCI mRNA CTD PMID:20106945 and PMID:21632981 Fanci Rat cyclosporin A affects expression ISO FANCI (Homo sapiens) 6480464 Cyclosporine affects the expression of FANCI mRNA CTD PMID:25562108 Fanci Rat dexamethasone multiple interactions ISO FANCI (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FANCI mRNA CTD PMID:28628672 Fanci Rat Dibutyl phosphate affects expression ISO FANCI (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of FANCI mRNA CTD PMID:37042841 Fanci Rat dichloroacetic acid increases expression ISO Fanci (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of FANCI mRNA CTD PMID:28962523 Fanci Rat dicrotophos decreases expression ISO FANCI (Homo sapiens) 6480464 dicrotophos results in decreased expression of FANCI mRNA CTD PMID:28302478 Fanci Rat digitoxin multiple interactions ISO FANCI (Homo sapiens) 6480464 Digitoxin inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCI protein] CTD PMID:24124520 Fanci Rat digoxin multiple interactions ISO FANCI (Homo sapiens) 6480464 Digoxin inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCI protein] CTD PMID:24124520 Fanci Rat dioxygen decreases expression ISO FANCI (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of FANCI mRNA CTD PMID:26516004 Fanci Rat doxorubicin affects response to substance ISO FANCI (Homo sapiens) 6480464 FANCI protein affects the susceptibility to Doxorubicin CTD PMID:16217747 Fanci Rat doxorubicin decreases expression ISO FANCI (Homo sapiens) 6480464 Doxorubicin results in decreased expression of FANCI mRNA CTD PMID:29803840 and PMID:30031762 Fanci Rat Enterolactone multiple interactions ISO FANCI (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCI mRNA CTD PMID:19167446 Fanci Rat enzyme inhibitor multiple interactions ISO FANCI (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FANCI protein CTD PMID:23301498 Fanci Rat FR900359 increases phosphorylation ISO FANCI (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of FANCI protein CTD PMID:37730182 Fanci Rat fragrance increases expression ISO FANCI (Homo sapiens) 6480464 Perfume results in increased expression of FANCI mRNA CTD PMID:24768652 Fanci Rat genistein increases expression ISO FANCI (Homo sapiens) 6480464 Genistein results in increased expression of FANCI mRNA CTD PMID:16474171 Fanci Rat hydrogen peroxide affects expression ISO FANCI (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of FANCI mRNA CTD PMID:21179406 Fanci Rat indometacin multiple interactions ISO FANCI (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FANCI mRNA CTD PMID:28628672 Fanci Rat ivermectin decreases expression ISO FANCI (Homo sapiens) 6480464 Ivermectin results in decreased expression of FANCI protein CTD PMID:32959892 Fanci Rat Lasiocarpine increases expression ISO FANCI (Homo sapiens) 6480464 lasiocarpine results in increased expression of FANCI mRNA CTD PMID:32234424 Fanci Rat lead(0) affects expression ISO FANCI (Homo sapiens) 6480464 Lead affects the expression of FANCI mRNA CTD PMID:28903495 Fanci Rat lucanthone decreases expression ISO FANCI (Homo sapiens) 6480464 Lucanthone results in decreased expression of FANCI mRNA CTD PMID:21148553 Fanci Rat manganese atom multiple interactions ISO FANCI (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FANCI mRNA CTD PMID:39836092 Fanci Rat manganese(0) multiple interactions ISO FANCI (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FANCI mRNA CTD PMID:39836092 Fanci Rat manganese(II) chloride multiple interactions ISO FANCI (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FANCI mRNA CTD PMID:39836092 Fanci Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of FANCI gene CTD PMID:35440735 Fanci Rat methyl methanesulfonate increases expression ISO FANCI (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of FANCI mRNA CTD PMID:23649840 Fanci Rat mitomycin C multiple interactions ISO FANCI (Homo sapiens) 6480464 Curcumin inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCI protein] more ... CTD PMID:24124520 Fanci Rat N-Nitrosopyrrolidine decreases expression ISO FANCI (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of FANCI mRNA CTD PMID:32234424 Fanci Rat ouabain decreases expression ISO FANCI (Homo sapiens) 6480464 Ouabain results in decreased expression of FANCI mRNA CTD PMID:24124520 Fanci Rat ouabain multiple interactions ISO FANCI (Homo sapiens) 6480464 Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCI protein] CTD PMID:24124520 Fanci Rat ozone decreases expression ISO Fanci (Mus musculus) 6480464 Ozone results in decreased expression of FANCI mRNA CTD PMID:24336422 Fanci Rat ozone multiple interactions ISO Fanci (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FANCI mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FANCI mRNA CTD PMID:34911549 Fanci Rat palbociclib decreases expression ISO FANCI (Homo sapiens) 6480464 palbociclib results in decreased expression of FANCI mRNA CTD PMID:22869556 Fanci Rat paracetamol increases expression ISO FANCI (Homo sapiens) 6480464 Acetaminophen results in increased expression of FANCI mRNA CTD PMID:22230336 Fanci Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of FANCI mRNA CTD PMID:33387578 Fanci Rat PCB138 multiple interactions ISO Fanci (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Fanci Rat perfluorooctanoic acid affects splicing ISO Fanci (Mus musculus) 6480464 perfluorooctanoic acid affects the splicing of FANCI mRNA CTD PMID:32320774 Fanci Rat phenethyl isothiocyanate decreases expression ISO FANCI (Homo sapiens) 6480464 phenethyl isothiocyanate results in decreased expression of FANCI mRNA CTD PMID:26678675 Fanci Rat piroxicam increases expression ISO FANCI (Homo sapiens) 6480464 Piroxicam results in increased expression of FANCI mRNA CTD PMID:21858171 Fanci Rat pregnenolone 16alpha-carbonitrile increases expression ISO Fanci (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of FANCI mRNA CTD PMID:22698814 Fanci Rat pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of FANCI mRNA CTD PMID:30047161 Fanci Rat progesterone increases expression ISO FANCI (Homo sapiens) 6480464 Progesterone results in increased expression of FANCI mRNA CTD PMID:18070364 Fanci Rat propanal decreases expression ISO FANCI (Homo sapiens) 6480464 propionaldehyde results in decreased expression of FANCI mRNA CTD PMID:26079696 Fanci Rat quercetin affects expression ISO FANCI (Homo sapiens) 6480464 Quercetin affects the expression of FANCI mRNA CTD PMID:21632981 Fanci Rat resveratrol multiple interactions ISO FANCI (Homo sapiens) 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of FANCI mRNA and [Plant Extracts co-treated with Resveratrol] results in increased expression of FANCI mRNA CTD PMID:19167446 and PMID:23557933 Fanci Rat sodium arsenite increases expression ISO FANCI (Homo sapiens) 6480464 sodium arsenite results in increased expression of FANCI mRNA CTD PMID:29301061 Fanci Rat sodium arsenite multiple interactions ISO FANCI (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FANCI mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FANCI mRNA CTD PMID:39836092 Fanci Rat sodium arsenite decreases expression ISO FANCI (Homo sapiens) 6480464 sodium arsenite results in decreased expression of FANCI mRNA CTD PMID:38568856 Fanci Rat sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of FANCI mRNA CTD PMID:30047161 Fanci Rat sunitinib decreases expression ISO FANCI (Homo sapiens) 6480464 Sunitinib results in decreased expression of FANCI mRNA CTD PMID:31533062 Fanci Rat T-2 toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of FANCI mRNA CTD PMID:26141394 Fanci Rat tert-butyl hydroperoxide decreases expression ISO FANCI (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of FANCI mRNA CTD PMID:15336504 Fanci Rat testosterone multiple interactions ISO FANCI (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of FANCI mRNA CTD PMID:21592394 Fanci Rat testosterone decreases expression ISO FANCI (Homo sapiens) 6480464 Testosterone results in decreased expression of FANCI mRNA CTD PMID:21592394 Fanci Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of FANCI mRNA CTD PMID:31150632 Fanci Rat thapsigargin decreases expression ISO FANCI (Homo sapiens) 6480464 Thapsigargin results in decreased expression of FANCI mRNA CTD PMID:22378314 Fanci Rat titanium dioxide increases expression ISO Fanci (Mus musculus) 6480464 titanium dioxide results in increased expression of FANCI mRNA CTD PMID:23557971 Fanci Rat titanium dioxide decreases methylation ISO Fanci (Mus musculus) 6480464 titanium dioxide results in decreased methylation of FANCI gene and titanium dioxide results in decreased methylation of FANCI promoter alternative form CTD PMID:35295148 Fanci Rat titanium dioxide affects expression ISO Fanci (Mus musculus) 6480464 titanium dioxide affects the expression of FANCI mRNA CTD PMID:29264374 Fanci Rat topotecan affects response to substance ISO FANCI (Homo sapiens) 6480464 FANCI protein affects the susceptibility to Topotecan CTD PMID:16217747 Fanci Rat trimellitic anhydride increases expression ISO Fanci (Mus musculus) 6480464 trimellitic anhydride results in increased expression of FANCI mRNA CTD PMID:19042947 Fanci Rat triphenyl phosphate affects expression ISO FANCI (Homo sapiens) 6480464 triphenyl phosphate affects the expression of FANCI mRNA CTD PMID:37042841 Fanci Rat triptonide affects expression ISO Fanci (Mus musculus) 6480464 triptonide affects the expression of FANCI mRNA CTD PMID:33045310 Fanci Rat trovafloxacin decreases expression ISO Fanci (Mus musculus) 6480464 trovafloxacin results in decreased expression of FANCI mRNA CTD PMID:35537566 Fanci Rat urethane decreases expression ISO FANCI (Homo sapiens) 6480464 Urethane results in decreased expression of FANCI mRNA CTD PMID:28818685 Fanci Rat valproic acid affects expression ISO FANCI (Homo sapiens) 6480464 Valproic Acid affects the expression of FANCI mRNA CTD PMID:25979313 Fanci Rat vorinostat increases expression ISO FANCI (Homo sapiens) 6480464 vorinostat results in increased expression of FANCI mRNA CTD PMID:27188386
1-naphthyl isothiocyanate (EXP) 17beta-estradiol (EXP,ISO) 2,2',4,4',5,5'-hexachlorobiphenyl (ISO) 2,2',5,5'-tetrachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-methylcholine (ISO) 2-palmitoylglycerol (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-sulfonyldiphenol (ISO) 5-fluorouracil (ISO) 6-propyl-2-thiouracil (EXP) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) all-trans-retinoic acid (ISO) amitrole (EXP) amphetamine (EXP) arsane (ISO) arsenic atom (ISO) arsenite(3-) (ISO) asbestos (ISO) avobenzone (ISO) azathioprine (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) Bisphenol A diglycidyl ether (ISO) bisphenol AF (ISO) bisphenol F (ISO) cadmium atom (ISO) cadmium dichloride (EXP,ISO) caffeine (ISO) calcitriol (ISO) cannabidiol (ISO) cantharidin (ISO) carbamazepine (ISO) carbon nanotube (ISO) chlorpyrifos (ISO) cisplatin (ISO) clotrimazole (EXP) cobalt dichloride (ISO) corosolic acid (ISO) coumarin (ISO) coumestrol (ISO) Cuprizon (EXP) curcumin (ISO) cyclosporin A (ISO) dexamethasone (ISO) Dibutyl phosphate (ISO) dichloroacetic acid (ISO) dicrotophos (ISO) digitoxin (ISO) digoxin (ISO) dioxygen (ISO) doxorubicin (ISO) Enterolactone (ISO) enzyme inhibitor (ISO) FR900359 (ISO) fragrance (ISO) genistein (ISO) hydrogen peroxide (ISO) indometacin (ISO) ivermectin (ISO) Lasiocarpine (ISO) lead(0) (ISO) lucanthone (ISO) manganese atom (ISO) manganese(0) (ISO) manganese(II) chloride (ISO) methoxychlor (EXP) methyl methanesulfonate (ISO) mitomycin C (ISO) N-Nitrosopyrrolidine (ISO) ouabain (ISO) ozone (ISO) palbociclib (ISO) paracetamol (EXP,ISO) PCB138 (ISO) perfluorooctanoic acid (ISO) phenethyl isothiocyanate (ISO) piroxicam (ISO) pregnenolone 16alpha-carbonitrile (EXP,ISO) progesterone (ISO) propanal (ISO) quercetin (ISO) resveratrol (ISO) sodium arsenite (ISO) sulfadimethoxine (EXP) sunitinib (ISO) T-2 toxin (EXP) tert-butyl hydroperoxide (ISO) testosterone (ISO) tetrachloromethane (EXP) thapsigargin (ISO) titanium dioxide (ISO) topotecan (ISO) trimellitic anhydride (ISO) triphenyl phosphate (ISO) triptonide (ISO) trovafloxacin (ISO) urethane (ISO) valproic acid (ISO) vorinostat (ISO)
1.
Identification of the Fanconi anemia complementation group I gene, FANCI.
Dorsman JC, etal., Cell Oncol. 2007;29(3):211-8.
2.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
3.
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
Girard E, etal., Int J Cancer. 2019 Apr 15;144(8):1962-1974. doi: 10.1002/ijc.31921. Epub 2018 Nov 13.
4.
OMIM Disease Annotation Pipeline
OMIM Disease Annotation Pipeline
5.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
6.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
7.
Comprehensive gene review and curation
RGD comprehensive gene curation
8.
Novel FANCI mutations in Fanconi anemia with VACTERL association.
Savage SA, etal., Am J Med Genet A. 2016 Feb;170A(2):386-91. doi: 10.1002/ajmg.a.37461. Epub 2015 Nov 21.
9.
Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
Wreesmann VB, etal., ORL J Otorhinolaryngol Relat Spec. 2007;69(4):218-25. Epub 2007 Apr 4.
Fanci Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 142,736,636 - 142,792,999 (+) NCBI GRCr8 mRatBN7.2 1 133,327,264 - 133,383,661 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 133,327,297 - 133,383,640 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 1 141,116,565 - 141,172,997 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 141,120,166 - 141,172,483 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 142,078,658 - 142,134,772 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 135,144,029 - 135,196,828 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 1 125,390,494 - 125,446,830 (+) NCBI Celera Cytogenetic Map 1 q31 NCBI
FANCI Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 15 89,243,979 - 89,317,259 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 15 89,243,945 - 89,317,261 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 15 89,787,210 - 89,860,490 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 15 87,588,198 - 87,661,366 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 15 66,188,469 - 66,261,721 (+) NCBI Celera Cytogenetic Map 15 q26.1 NCBI HuRef 15 65,899,078 - 65,972,245 (+) NCBI HuRef CHM1_1 15 89,628,176 - 89,701,402 (+) NCBI CHM1_1 T2T-CHM13v2.0 15 86,998,773 - 87,072,086 (+) NCBI T2T-CHM13v2.0
Fanci Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 7 79,042,056 - 79,100,013 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 7 79,041,677 - 79,100,012 (+) Ensembl GRCm39 Ensembl GRCm38 7 79,392,312 - 79,450,266 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 7 79,391,929 - 79,450,264 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 7 86,537,224 - 86,595,150 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 7 79,265,866 - 79,323,777 (+) NCBI MGSCv36 mm8 Celera 7 76,790,497 - 76,852,630 (+) NCBI Celera Cytogenetic Map 7 D2 NCBI cM Map 7 45.01 NCBI
Fanci Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955416 15,788,922 - 15,853,480 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955416 15,788,812 - 15,857,933 (-) NCBI ChiLan1.0 ChiLan1.0
FANCI Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 16 78,791,536 - 78,864,917 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 15 82,496,027 - 82,569,303 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 15 67,935,882 - 68,009,033 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 15 87,142,871 - 87,215,271 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 15 87,142,871 - 87,215,271 (+) Ensembl panpan1.1 panPan2
FANCI Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 3 52,282,955 - 52,357,874 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 3 52,282,731 - 52,357,226 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 3 54,917,864 - 54,992,648 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 3 52,700,699 - 52,774,876 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 3 52,700,713 - 52,774,871 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 3 52,223,438 - 52,297,602 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 3 52,433,730 - 52,507,862 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 3 52,772,736 - 52,847,574 (+) NCBI UU_Cfam_GSD_1.0
Fanci Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024408640 131,154,626 - 131,236,280 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936483 15,106,902 - 15,179,094 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936483 15,096,215 - 15,179,856 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
FANCI Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 7 54,811,027 - 54,889,998 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 7 54,811,024 - 54,889,992 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 7 59,782,093 - 59,865,530 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
FANCI Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 29 7,788,983 - 7,864,505 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 29 7,790,458 - 7,855,552 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666059 38,950,782 - 39,037,352 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Fanci
.
Predicted Target Of
Count of predictions: 139 Count of miRNA genes: 112 Interacting mature miRNAs: 120 Transcripts: ENSRNOT00000022638, ENSRNOT00000050759 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
61442 Strs1 Sensitivity to stroke QTL 1 7.4 cerebrum integrity trait (VT:0010549) post-insult time to onset of cerebrovascular lesion (CMO:0002343) 1 121767634 166767634 Rat 1578780 Cm52 Cardiac mass QTL 52 3.3 0.0001 heart mass (VT:0007028) heart wet weight (CMO:0000069) 1 81591954 219808434 Rat 1578654 Bss10 Bone structure and strength QTL 10 4 femur morphology trait (VT:0000559) femoral neck cortical cross-sectional area (CMO:0001702) 1 49393172 159356837 Rat 1598866 Bp287 Blood pressure QTL 287 5.1 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 121006655 166006655 Rat 1578770 Stresp23 Stress response QTL 23 kidney sympathetic nerve activity (VT:0004050) stimulated renal sympathetic nerve activity to basal renal sympathetic nerve activity ratio (CMO:0001786) 1 123350408 182418476 Rat 9590300 Scort16 Serum corticosterone level QTL 16 4.39 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 1 103111621 148111621 Rat 2298545 Neuinf8 Neuroinflammation QTL 8 4.6 nervous system integrity trait (VT:0010566) spinal cord beta-2 microglobulin mRNA level (CMO:0002125) 1 57336763 151090257 Rat 7794788 Mcs32 Mammary carcinoma susceptibility QTL 32 2.61 mammary gland integrity trait (VT:0010552) mammary tumor incidence/prevalence measurement (CMO:0000946) 1 115540693 238914717 Rat 631199 Cm23 Cardiac mass QTL 23 4.6 0.0004 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 1 115585465 172949803 Rat 2313402 Anxrr24 Anxiety related response QTL 24 aggression-related behavior trait (VT:0015014) tameness/aggressiveness composite score (CMO:0002136) 1 48963584 144267916 Rat 1598850 Bp297 Blood pressure QTL 297 2.1 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 121006655 166006655 Rat 631570 Bp94 Blood pressure QTL 94 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 123479780 142990467 Rat 152025235 Bw194 Body weight QTL 194 4.86 body mass (VT:0001259) 1 123556856 242907031 Rat 152025232 Bw192 Body weight QTL 192 3.93 body mass (VT:0001259) 1 117917486 196963478 Rat 724521 Uae1 Urinary albumin excretion QTL 1 3.8 0.0001 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 90508614 173018436 Rat 1358902 Bw47 Body weight QTL 47 1.67 body mass (VT:0001259) body weight (CMO:0000012) 1 90508614 180359386 Rat 61346 Rf2 Renal disease susceptibility QTL 2 3.7 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 1 99267916 144267916 Rat 8655649 Arrd1 Age-related retinal degeneration QTL 1 4.89 retinal layer morphology trait (VT:0003727) percentage of study population developing retinopathy during a period of time (CMO:0002453) 1 100357752 183970443 Rat 1300153 Bp171 Blood pressure QTL 171 3.37 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 1 90664883 143200202 Rat 2317833 Alcrsp19 Alcohol response QTL 19 12.4 0.001 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 1 100979852 145979852 Rat 731168 Bp154 Blood pressure QTL 154 3.4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 94642644 214537671 Rat 631202 Gluco13 Glucose level QTL 13 0.0001 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 131763437 159756369 Rat 631205 Bp196 Blood pressure QTL 196 4 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 118944897 199050459 Rat 1300158 Bp173 Blood pressure QTL 173 3.48 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 1 115540693 185145286 Rat 1641897 Alcrsp1 Alcohol response QTL 1 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 1 100979852 145979852 Rat 1331749 Hrtrt11 Heart rate QTL 11 2.973 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 1 94494440 198211706 Rat 1331751 Bp199 Blood pressure QTL 199 3.60022 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 1 94494440 181830018 Rat 2293142 Bp314 Blood pressure QTL 314 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 92184926 137184926 Rat 9685799 Bp375 Blood pressure QTL 375 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 125611501 170611501 Rat 2293140 Bp313 Blood pressure QTL 313 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 121833674 166833674 Rat 9685802 Bp376 Blood pressure QTL 376 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 126540680 171540680 Rat 724529 Cm16 Cardiac mass QTL 16 2.7 heart mass (VT:0007028) calculated heart weight (CMO:0000073) 1 87580395 150700247 Rat 61370 Mcs3 Mammary carcinoma susceptibility QTL 3 2.15 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 1 102268556 147268556 Rat 1641895 Bp298 Blood pressure QTL 298 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 123350408 182418476 Rat 70209 Niddm23 Non-insulin dependent diabetes mellitus QTL 23 2.82 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 94494440 198324465 Rat 631496 Bp97 Blood pressure QTL 97 3.08 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 106047847 151047847 Rat 634314 Niddm44 Non-insulin dependent diabetes mellitus QTL 44 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 49393289 199050459 Rat 2303591 Gluco41 Glucose level QTL 41 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 102168504 147168504 Rat 1331793 Bp200 Blood pressure QTL 200 3.71601 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 94494440 172949803 Rat 2313060 Bss71 Bone structure and strength QTL 71 2.6 0.0001 long bone metaphysis morphology trait (VT:0000133) tibia midshaft total cross-sectional area (CMO:0001715) 1 118944747 163944747 Rat 1354591 Cm36 Cardiac mass QTL 36 4.1 heart left ventricle mass (VT:0007031) calculated heart weight (CMO:0000073) 1 102813953 201278233 Rat 7421630 Bp362 Blood pressure QTL 362 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 118608292 241799120 Rat 70225 Bp58 Blood pressure QTL 58 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 32356093 162846471 Rat 10059597 Bp377 Blood pressure QTL 377 3.42 0.025 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 32737458 199368955 Rat 61399 Tcat1 Tongue tumor resistance QTL 1 3.3 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 5 mm (CMO:0001879) 1 99267916 144267916 Rat 724567 Tcas6 Tongue tumor susceptibility QTL 6 6.85 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 1 92948896 144267916 Rat 738006 Anxrr14 Anxiety related response QTL 14 4 0.00035 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 1 130636910 175636910 Rat 1354615 Cm32 Cardiac mass QTL 32 5.2 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 1 102813953 201278233 Rat 634348 Bp138 Blood pressure QTL 138 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 125611501 168883176 Rat 8694370 Bw154 Body weight QTL 154 8.91 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 1 103111621 148111621 Rat 738028 Anxrr12 Anxiety related response QTL 12 4.9 0.00001 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 1 130636910 175636910 Rat 1354623 Rf46 Renal function QTL 46 3.8 blood creatinine amount (VT:0005328) plasma creatinine level (CMO:0000537) 1 102813953 151162766 Rat 631654 Bp107 Blood pressure QTL 107 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 125611501 170611501 Rat 631544 Bp84 Blood pressure QTL 84 5.6 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 123350408 181759564 Rat 152025212 Bw190 Body weight QTL 190 5.7 body mass (VT:0001259) 1 123556856 196963478 Rat 631549 Bp89 Blood pressure QTL 89 5.7 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 123350581 201284552 Rat 1358189 Cstrr1 Cold stress response QTL 1 0.0001 catecholamine amount (VT:0010543) urine norepinephrine level (CMO:0001629) 1 123350408 182418476 Rat 1354606 Bp246 Blood pressure QTL 246 3.6 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 1 102813953 218753816 Rat
D7Jpk3
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 133,367,773 - 133,367,920 (+) MAPPER mRatBN7.2 Rnor_6.0 1 141,157,067 - 141,157,213 NCBI Rnor6.0 Rnor_5.0 1 142,119,155 - 142,119,301 UniSTS Rnor5.0 RGSC_v3.4 1 135,180,930 - 135,181,076 UniSTS RGSC3.4 Celera 1 125,430,964 - 125,431,110 UniSTS
RH141225
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 133,382,792 - 133,382,972 (+) MAPPER mRatBN7.2 Rnor_6.0 1 141,172,146 - 141,172,325 NCBI Rnor6.0 Rnor_5.0 1 142,133,921 - 142,134,100 UniSTS Rnor5.0 RGSC_v3.4 1 135,196,491 - 135,196,670 UniSTS RGSC3.4 Celera 1 125,445,979 - 125,446,158 UniSTS RH 3.4 Map 1 1412.89 UniSTS
MARC_7859-7860:996688105:3
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 1 142,792,761 - 142,793,348 (+) Marker Load Pipeline mRatBN7.2 1 133,383,406 - 133,383,993 (+) MAPPER mRatBN7.2 Rnor_6.0 1 141,172,760 - 141,173,346 NCBI Rnor6.0 Rnor_5.0 1 142,134,535 - 142,135,121 UniSTS Rnor5.0 RGSC_v3.4 1 135,197,105 - 135,197,691 UniSTS RGSC3.4 Celera 1 125,446,593 - 125,447,179 UniSTS Cytogenetic Map 1 q31 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000050759 ⟹ ENSRNOP00000043744
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 133,330,850 - 133,383,493 (+) Ensembl Rnor_6.0 Ensembl 1 141,120,166 - 141,172,483 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000110421 ⟹ ENSRNOP00000095393
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 133,327,297 - 133,383,640 (+) Ensembl
RefSeq Acc Id:
NM_001427670 ⟹ NP_001414599
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 142,736,653 - 142,792,999 (+) NCBI
RefSeq Acc Id:
XM_039101037 ⟹ XP_038956965
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 142,736,636 - 142,792,999 (+) NCBI mRatBN7.2 1 133,327,264 - 133,383,661 (+) NCBI
Ensembl Acc Id:
ENSRNOP00000043744 ⟸ ENSRNOT00000050759
RefSeq Acc Id:
XP_038956965 ⟸ XM_039101037
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I6ANG0 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000095393 ⟸ ENSRNOT00000110421
RefSeq Acc Id:
NP_001414599 ⟸ NM_001427670
- UniProtKB:
D3Z840 (UniProtKB/TrEMBL), A0A8I6ANG0 (UniProtKB/TrEMBL)
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2018-05-25
Fanci
FA complementation group I
Fanci
Fanconi anemia, complementation group I
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2010-12-08
Fanci
Fanconi anemia, complementation group I
LOC100360594
Fanconi anemia, complementation group I
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2010-05-06
LOC100360594
Fanconi anemia, complementation group I
Symbol and Name status set to provisional
70820 PROVISIONAL
